Industry·June 8, 2026

Trump Announces 160 Additional Drugs Added to TrumpRx Direct-to-Consumer Platform

President Trump announced Friday that TrumpRx.gov will add 160 prescription medications to its direct-to-consumer platform, bringing the total to over 800 drugs. This marks the second expansion in two months of the federal government's discounted drug initiative. The platform sells medications directly to consumers at reduced prices. No timeline for implementation or specific drug categories were detailed in the announcement.

Why it matters for managed care

Direct federal drug purchasing could affect Medicaid managed care pharmacy benefit management, prescription rebate negotiations, and member utilization patterns if beneficiaries access medications outside MCO formularies.

Pharmacy · Managed Care

Read the full article at thehill.com →

Share this briefing